bioRxiv Science⌕ Search

Biology subjects

Wen, Z.-Y.

Publications and source records attributed to Wen, Z.-Y..

2 recordsLinked to original sources

Markonv: a novel convolutional layer with inter-positional correlations modeled

Deep neural networks equipped with convolutional neural layers have been widely used in omics data analysis. Though highly efficient in data-oriented feature detection, the classical convolutional layer is designed with inter-positional independent filters, hardly modeling inter-positional correlations in various biological data. Here, we proposed Markonv layer (Markov convolutional neural layer), a novel convolutional neural layer with Markov transition matrices as its filters, to model the intrinsic dependence in inputs as Markov processes. Extensive evaluations based on both synthetic and real-world data showed that Markonv-based networks could not only identify functional motifs with inter-positional correlations in large-scale omics sequence data effectively, but also decode complex electrical signals generated by Oxford Nanopore sequencing efficiently. Designed as a drop-in replacement of the classical convolutional layer, Markonv layers enable an effective and efficient identification for inter-positional correlations from various biological data of different modalities. All source codes of a PyTorch-based implementation are publicly available on GitHub for academic usage.

bioinformatics↗

Homo-harringtonine (HHT) - A highly effective drug against coronaviruses and the potential for large-scale clinical applications

In the search for treatment schemes of COVID-19, we start by examining the general weakness of coronaviruses and then identify approved drugs attacking that weakness. The approach, if successful, should identify drugs with a specific mechanism that is at least as effective as the best drugs proposed and are ready for clinical trials. All coronaviruses translate their non-structural proteins ([~]16) in concatenation, resulting in a very large super-protein. Homo-harringtonine (HHT), which has been approved for the treatment of leukemia, blocks protein elongation very effectively. Hence, HHT can repress the replication of many coronaviruses at the nano-molar concentration. In two mouse models, HHT clears SARS-CoV-2 in 3 days, especially by nasal dripping of 40 ug per day. We also use dogs to confirm the safety of HHT delivered by nebulization. The nebulization scheme could be ready for large-scale applications at the onset of the next epidemics. For the current COVID-19, a clinical trial has been approved by the Ditan hospital of Beijing but could not be implemented for want of patients. The protocol is available to qualified medical facilities.

microbiology↗